Yüklüyor......
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
Increasing interest in repurposing the diabetic medication metformin for cancer treatment has raised important questions about the translation of promising preclinical findings to therapeutic efficacy, especially in non-diabetic patients. A significant limitation of the findings to date is the use o...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4695136/ https://ncbi.nlm.nih.gov/pubmed/26172303 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|